Two decentralized science altcoins are experiencing fluctuations in value following their addition to Coinbase, a leading US-based cryptocurrency exchange platform.
Coinbase recently announced the inclusion of two decentralized science (DeSci) protocols – Bio Protocol (BIO) and ResearchCoin (RSC) – in their range of cryptocurrency offerings.
After the announcements, both tokens saw a decline in their prices.
“ResearchCoin and Bio Protocol are now available on Coinbase’s website and mobile apps. Customers can engage in various transactions involving these assets.”
At the time of writing, BIO is trading at $0.0612, marking a 7.3% decrease for the day, while RSC is valued at $0.493, reflecting a 34% drop in price over the past 24 hours.
Earlier this week, Coinbase also extended support for RSC, a project supported by Coinbase CEO Brian Armstrong, which aims to enhance science communication and research on Base, Coinbase’s proprietary blockchain, leading to a price surge for the asset.
According to its official website, Bio Protocol enables users to contribute to early-stage biotech funding, thereby expediting developments in the field.
“Our goal is to revolutionize the process of biotech breakthroughs by empowering global communities to collaborate on funding and developing new biotechnologies from inception. Bio facilitates fundraising for research, creating value from it, and distributing that value through commercial successes. By eliminating traditional barriers in biotech and introducing a permissionless framework, Bio accelerates life-saving discoveries and makes them more accessible to all.”
Follow us on X, Facebook and Telegram
Don’t Miss a Beat – Subscribe to get email alerts delivered directly to your inbox
Check Price Action
Surf The Daily Hodl Mix
Featured Image: Shutterstock/Salamahin/HUT Design